title: The role of the perfusion balloon catheter after an initially unsuccessful coronary intervention.
abstract: Major dissection and acute closure following conventional percutaneous transluminal coronary angioplasty (PTCA) occur in 5%-10% of cases and lead to significant morbidity. Newer percutaneous modalities such as directional coronary atherectomy (DCA), excimer laser coronary angioplasty (ELCA), rotational ablation, and transluminal extraction atherectomy (TEC) can also be complicated by dissection and acute closure. Redilatation with conventional balloon catheters can reestablish patency of the artery or improve flow in a minority of cases. The perfusion balloon catheter (PBC) has several advantages over conventional balloon angioplasty in this situation. In approximately 70% of these cases, subsequent use of a PBC yields an acceptable clinical and angiographic result. The PBC permits rapid resolution of ischemia caused by acute closure or a flow-limiting dissection. New modifications of the PBC make it possible to position the catheter in nearly all segments of the coronary arterial tree including locations not accessible to other modalities, such as coronary stents or DCA, that are also used for salvage after a failed coronary intervention. Even if the PBC does not yield a definitive result, it allows rapid restoration of antegrade flow prior to coronary artery bypass grafting or coronary stent placement. Because of its ease of use, wide applicability, and efficacy, the PBC should be considered as the initial means of treatment in cases of major dissection or acute closure following any modality of percutaneous coronary revascularization.
authors.affiliation: Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
authors.forename: B
authors.initials: B
authors.lastname: Armstrong
authors.forename: M H
authors.initials: MH
authors.lastname: Sketch
authors.forename: R S
authors.initials: RS
authors.lastname: Stack
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D002404:Catheterization; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000628:therapy*; D006801:Humans; D015425:Myocardial Reperfusion; D017211:Treatment Failure